Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

S. Korea Weighs Lab Return Of Disgraced Cloning Scientist (S. Korea)

This article was originally published in PharmAsia News

Executive Summary

South Korea's Ministry of Health is weighing a request by a disgraced cloning scientist to be allowed to conduct embryonic stem cell research once again, this time not as a team leader. Hwang Woo-suk and his base laboratory, Suam Bioengineering Research Institute, applied to the ministry's director in charge of bioethics safety for permission to do the research. The same type of work led to Hwang's downfall after it was discovered he and his team faked laboratory results, an issue still alive in the courts. The institute plans to return to Hwang's project of using somatic cells from specific patients to grow stem cells tailored to that patient. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel